← All diseases Liver, kidneys and digestion

Fatty liver disease (MASH/NASH), advanced

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (129)Meta-analysis (42)Randomized Trial (40)Systematic review (32)Phase 3 Study (15)Clinical research (223)Overview article (431)Early study (phase 1 or 2) (12)Laboratory or animal research (274)Single Patient Description (18)Commentary or Editorial (50)Retracted Publication (4) Studies currently seeking participants only (40)

Filter

Publications and studies (2550)

• The acidic pathway of bile acid synthesis: Not just an alternative pathway(☆). (2019/05/21) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet. (2019/05/11) ♡
• Incidence of Recurrent NASH-Related Allograft Cirrhosis. (2019/05/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Quantitative ultrasound and machine learning for assessment of steatohepatitis in a rat model. (2019/05/01) ♡
• Dietary patterns and non-alcoholic fatty liver disease in a Greek case-control study. (2019/05/01) ♡
• No association between fruits or vegetables and non-alcoholic fatty liver disease in middle-aged men and women. (2019/05/01) ♡
• Ideal cardiovascular health associated with fatty liver: Results from a multi-ethnic survey. (2019/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Outside the liver box: The gut microbiota as pivotal modulator of liver diseases. (2019/05/01) ♡
• Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity. (2019/04/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish. (2019/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors. (2019/04/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. (2019/04/01) ♡
• Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress. (2019/04/01) ♡
• Raw orange intake is associated with higher prevalence of non-alcoholic fatty liver disease in an adult population. (2019/04/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Evaluation of metformin therapy using controlled attenuation parameter and transient elastography in patients with non-alcoholic fatty liver disease. (2019/04/01) ♡
• [Analysis on mechanisms and medication rules of herbal prescriptions for nonalcoholic fatty liver disease based on methods of data mining and biological information]. (2019/04/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice. (2019/03/26) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha. (2019/03/25) ♡
• [Acupuncture improves hepatic lipid metabolism by suppressing oxidative stress in obese nonalcoholic fatty liver disease rats]. (2019/03/25) ♡
• Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load. (2019/03/19) ♡
• Ursodeoxycholic Acid Regulates Hepatic Energy Homeostasis and White Adipose Tissue Macrophages Polarization in Leptin-Deficiency Obese Mice. (2019/03/16) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases. (2019/03/08) ♡
• Caffeine-stimulated muscle IL-6 mediates alleviation of non-alcoholic fatty liver disease. (2019/03/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study. (2019/03/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice. (2019/03/01) ♡
• Repeated clodronate-liposome treatment results in neutrophilia and is not effective in limiting obesity-linked metabolic impairments. (2019/03/01) ♡
• Administration of methyl palmitate prevents non-alcoholic steatohepatitis (NASH) by induction of PPAR-α. (2019/03/01) ♡
• A higher flavonoid intake is associated with less likelihood of nonalcoholic fatty liver disease: results from a multiethnic study. (2019/03/01) ♡
• Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice. (2019/03/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis. (2019/03/01) ♡
• Low fat but not soy protein isolate was an effective intervention to reduce nonalcoholic fatty liver disease progression in C57BL/6J mice: monitored by a novel quantitative ultrasound (QUS) method. (2019/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Efficacy of curcumin/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials. (2019/03/01) ♡
• Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography. (2019/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Systems Challenges of Hepatic Carcinomas: A Review. (2019/03/01) ♡
• Effect of Soothing Gan (Liver) and Invigorating Pi (Spleen) Recipes on TLR4-p38 MAPK Pathway in Kupffer Cells of Non-alcoholic Steatohepatitis Rats. (2019/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism. (2019/02/23) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Lipidomic analysis reveals the efficiency of Eclipta prostrata on diet-induced nonalcoholic fatty liver disease in rats. (2019/02/20) ♡
• Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe-mediated steatosis prevention and recovery. (2019/02/13) ♡
• Nonalcoholic fatty liver disease and sarcopenia in a Western population (NHANES III): The importance of sarcopenia definition. (2019/02/01) ♡
• SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis. (2019/02/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol. (2019/02/01) ♡
• STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis. (2019/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Role of socio-economic status in observational studies: A study model on non-alcoholic steato-hepatitis (NASH). (2019/02/01) ♡
• High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study. (2019/02/01) ♡
• Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi. (2019/02/01) ♡
• Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function. (2019/02/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Noninvasive diagnosis of nonalcoholic steatohepatitis: Emerging approaches. (2019/02/01) ♡
• Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor. (2019/02/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Effect of Zataria multiflora on fatty liver disease. (2019/02/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Effect of Zataria multiflora on fatty liver disease. (2019/02/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.